![](/images/Email.png)
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics
US Patent
Hepatikos Therapeutics
US Patent
Affinity DataIC50: 5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)